ArticleFrontiers in neuroscience2022
Learn Less, Infer More: Learning in the Fourier Domain for Quantitative Susceptibility Mapping.
Article in Frontiers in neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bibliometric analysis of global research trends in magnetic resonance imaging studies of substantia nigra in Parkinson's disease (2001-2024).Frontiers in aging neuroscience · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Quantitative susceptibility mapping (QSM) aims to evaluate the distribution of magnetic susceptibility from magnetic resonance phase measurements by solving the ill-conditioned dipole inversion problem. Removing the artifacts and preserving the anisotropy of tissue susceptibility simultaneously is still a challenge in QSM. To deal with this issue, a novel k-QSM network is proposed to resolve dipole inversion issues in QSM reconstruction. The k-QSM network converts the results obtained by truncated k-space division (TKD) into the Fourier domain as inputs. After passing through several convolutional and residual blocks, the ill-posed signals of TKD are corrected by making the network output close to the calculation of susceptibility through multiple orientation sampling (COSMOS)-labeled QSM. To evaluate the superiority of k-QSM, comparisons with several state-of-the-art methods are performed in terms of QSM artifacts removing, anisotropy preserving, generalization ability, and clinical applications. Compared to existing methods, the k-QSM achieves a 22.31% lower normalized root mean square error, 10.30% higher peak signal-to-noise ratio (PSNR), 33.10% lower high-frequency error norm, and 1.06% higher structural similarity. In addition, the orientation-dependent susceptibility variation obtained by k-QSM is significant, verifying that k-QSM has the ability to preserve susceptibility anisotropy. When the trained models are tested on the dataset from different centers, our k-QSM shows a strong generalization ability with the highest PSNR. Moreover, by comparing the susceptibility maps between healthy controls and drug addicts with different methods, we found the proposed k-QSM is more sensitive to the susceptibility abnormality in the patients. The proposed k-QSM method learns less-only to fix the ill-posed signals of TKD, but infers more-both COSMOS-like and anisotropy-preserving QSM results. Its generalization ability and great sensitivity to susceptibility changes can make it a potential method for distinguishing some diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.